Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Humanwell Chengtian Pharmaceutical is a specialized pharmaceutical manufacturing subsidiary of Humanwell Healthcare Group, located in Dangyang, Hubei Province, China. The company is a critical component of Humanwell's supply chain, focusing on the production of active pharmaceutical ingredients (APIs) and finished drug products. Its core expertise lies in the development and large-scale synthesis of small molecule therapeutics for central nervous system disorders, particularly in anesthesia and analgesia. The facility operates under strict GMP standards and supplies both domestic Chinese markets and international partners. By leveraging the research capabilities of its parent group, Humanwell Chengtian ensures the consistent delivery of essential medications such as anesthetics and pain relievers. The company plays a vital role in maintaining Humanwell's market-leading position in the specialized narcotics and psychotropic drug sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hubei Renfu Chengtian Pharmaceutical.